Sweden
· Delayed Price · Currency is SEK Enzymatica AB Statistics
Total Valuation
Enzymatica AB has a market cap or net worth of SEK 366.81 million. The enterprise value is 272.42 million.
| Market Cap | 366.81M |
| Enterprise Value | 272.42M |
Important Dates
The last earnings date was Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Enzymatica AB has 215.77 million shares outstanding. The number of shares has increased by 5.39% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 215.77M |
| Shares Change (YoY) | +5.39% |
| Shares Change (QoQ) | +8.15% |
| Owned by Insiders (%) | 21.18% |
| Owned by Institutions (%) | 0.02% |
| Float | 170.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.65 |
| PB Ratio | 1.94 |
| P/TBV Ratio | 2.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.05 |
| EV / Sales | 6.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.32 |
Financial Position
The company has a current ratio of 6.08, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.08 |
| Quick Ratio | 5.49 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.06 |
| Interest Coverage | -21.43 |
Financial Efficiency
Return on equity (ROE) is -38.33% and return on invested capital (ROIC) is -21.04%.
| Return on Equity (ROE) | -38.33% |
| Return on Assets (ROA) | -18.52% |
| Return on Capital (ROIC) | -21.04% |
| Revenue Per Employee | 2.60M |
| Profits Per Employee | -3.17M |
| Employee Count | 18 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 1.26 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.15% in the last 52 weeks. The beta is -0.01, so Enzymatica AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | -55.15% |
| 50-Day Moving Average | 1.84 |
| 200-Day Moving Average | 2.38 |
| Relative Strength Index (RSI) | 40.31 |
| Average Volume (20 Days) | 69,429 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Enzymatica AB had revenue of SEK 44.25 million and -53.96 million in losses. Loss per share was -0.31.
| Revenue | 44.25M |
| Gross Profit | 29.36M |
| Operating Income | -52.13M |
| Pretax Income | -54.23M |
| Net Income | -53.96M |
| EBITDA | -49.05M |
| EBIT | -52.13M |
| Loss Per Share | -0.31 |
Balance Sheet
The company has 96.90 million in cash and 2.52 million in debt, giving a net cash position of 94.38 million or 0.44 per share.
| Cash & Cash Equivalents | 96.90M |
| Total Debt | 2.52M |
| Net Cash | 94.38M |
| Net Cash Per Share | 0.44 |
| Equity (Book Value) | 189.49M |
| Book Value Per Share | 0.88 |
| Working Capital | 107.39M |
Cash Flow
In the last 12 months, operating cash flow was -42.56 million and capital expenditures -530,000, giving a free cash flow of -43.09 million.
| Operating Cash Flow | -42.56M |
| Capital Expenditures | -530,000 |
| Free Cash Flow | -43.09M |
| FCF Per Share | -0.20 |
Margins
Gross margin is 66.35%, with operating and profit margins of -117.81% and -121.95%.
| Gross Margin | 66.35% |
| Operating Margin | -117.81% |
| Pretax Margin | -122.56% |
| Profit Margin | -121.95% |
| EBITDA Margin | -110.85% |
| EBIT Margin | -117.81% |
| FCF Margin | -97.38% |
Dividends & Yields
Enzymatica AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.39% |
| Shareholder Yield | -5.39% |
| Earnings Yield | -18.34% |
| FCF Yield | -11.75% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |